InvestSMART

InhaleRx Limited (ASX: IRX) - Share Price

Current share price for IRX : $0.028 0.003 (12%)+

IRX General Information +

ASX Code IRX
Website N/A
Industry/Sector n/a
Market Cap ($M) n/a
IRX Share Price $0.028
Day High $0.030
Day Low $0.025
Last Close $0.025
IRX Share Price Movement $0.00 ( 12% )
Prices as at 16:41, 16 Feb 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

InhaleRx Limited (IRX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from InhaleRx Limited (IRX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

InhaleRx Limited (IRX) price-sensitive announcements

IRX - Dec25 Quarterly Activities Report
InhaleRx Limited's quarterly report for the period ended 31 December 2025 details the ongo
InhaleRx Limited (IRX)
29 Jan 2026 | 1:25 PM
IRX - Dec25 Appendix 4C Cash Flow Report
The document is the Appendix 4C quarterly cash flow report for InhaleRx Limited for the qu
InhaleRx Limited (IRX)
29 Jan 2026 | 1:16 PM
IRX - IRX Overview Presentation - SRX-25 and Nexalis
InhaleRx Limited, a clinical stage drug development company, is currently focused on devel
InhaleRx Limited (IRX)
10 Dec 2025 | 10:24 AM
IRX - $12.6m Facility to Drive SRX-25 Development
InhaleRx Limited has secured an additional $12.6 million funding from Linlithgow Family Of
InhaleRx Limited (IRX)
4 Dec 2025 | 9:31 AM

InhaleRx Limited (IRX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
InhaleRx Limited (IRX)
ORDINARY FULLY PAID
 Health Care - Change of Company Name and ASX Ticker - NX1 12 Feb 2026 6:20PM $0.025 $0.028 risen by 12%
InhaleRx Limited (IRX)
ORDINARY FULLY PAID
 Health Care - Proposed issue of securities - IRX 12 Feb 2026 5:26PM $0.025 $0.028 risen by 12%
InhaleRx Limited (IRX)
ORDINARY FULLY PAID
 Health Care - Clinical Development Outlook 2026 Presentation Slides 12 Feb 2026 2:07PM $0.024 $0.028 risen by 16.67%
InhaleRx Limited (IRX)
ORDINARY FULLY PAID
 Health Care - 2026 Clinical Development Outlook Webinar 9 Feb 2026 1:22PM $0.024 $0.028 risen by 16.67%
InhaleRx Limited (IRX)
ORDINARY FULLY PAID
 Health Care - Results of General Meeting 29 Jan 2026 6:33PM $0.025 $0.028 risen by 12%
InhaleRx Limited (IRX)
ORDINARY FULLY PAID
 Health Care - General Meeting Slides 29 Jan 2026 3:55PM $0.025 $0.028 risen by 12%

InhaleRx Limited (IRX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
23 Dec 2025 WILLIAMS, Sean Issued Indirect Shares 42,777 $0.025 $1,069.425
23 Dec 2025 WISE, Ronald Issued Indirect Shares 113,317 $0.025 $2,832.925
8 Jul 2025 WILLIAMS, Sean Issued Related Securities 1,074,866 $0.040 $42,994.640

See all changes in directors' interest & trades for InhaleRx Limited (IRX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.